2 Top Growth Stocks Down 24% and 50% to Buy With $100

The healthcare industry offers plenty of opportunities for long-term investors to invest in companies that are making a difference in patient care. Investing in the stock market doesn’t require a large amount of money, and even with just $100, you can start building your portfolio. Here are two healthcare companies that have recently seen a decrease in their stock prices, making them attractive options for investors:

1. Pfizer (NYSE: PFE) has experienced changes in its growth trajectory after the success of its COVID-19 products. Despite a 24% decrease in its stock price over the past year, Pfizer has been making strategic acquisitions and investing in research and development. The company had the most products approved by the FDA last year, with analysts predicting many of them to be blockbusters. Pfizer is also working on developing new drugs, including an obesity drug candidate. The company aims to launch 19 new products or indications, with the goal of adding $20 billion in annual revenue by 2030. Pfizer remains a strong player in the healthcare industry, with a solid dividend yield of 6%.

2. Teladoc Health (NYSE: TDOC) has seen its stock price drop by 50% over the past year. The company was a leader in the telehealth space before the pandemic, but its growth accelerated during the pandemic due to increased demand for virtual care services. Despite recent challenges, including multibillion-dollar impairment charges and the departure of its CEO, Teladoc is focusing on cost savings and future growth opportunities. In the first quarter of 2024, total revenue grew 3% year over year, with chronic care enrollment increasing by 9%. While the company is still unprofitable according to GAAP, adjusted earnings rose 20% in the recent quarter. Teladoc remains a promising player in the telehealth industry.

Both Pfizer and Teladoc present opportunities for investors looking to add healthcare companies to their portfolio. While there are risks involved, these companies have the potential for long-term growth and are worth considering for investors with $100 to invest.

Comments (0)
Add Comment